Interpretable machine learning for predicting residual cancer burden following neoadjuvant therapy in HER2 positive breast cancer: A real-world study

Accurate early prediction of response to neoadjuvant therapy (NAT) in HER2-positive breast cancer could support pre-treatment risk stratification. We conducted a retrospective real-world study of 692 patients treated between November 2018 and May 2025 at a tertiary center to develop interpretable machine-learning models for pre-treatment prediction of residual cancer burden (RCB; favorable: RCB 0–I vs. poor: RCB II–III). Least absolute shrinkage and selection operator identified nine routinely available predictors, and ten algorithms were trained with 10-fold cross-validation and grid search. Among them, a gradient boosting machine (GBM) achieved the best discrimination in the independent test set (AUC 0.796) with superior calibration and net clinical benefit. SHAP highlighted HER2 status, hormone-receptor status and clinical nodal stage as the strongest contributors, consistent with biological expectations. We implemented a Shiny web application for research and educational use. In a propensity score–matched comparison of trastuzumab–pertuzumab versus trastuzumab– pyrotinib regimens, no significant difference in achieving favorable RCB was observed. This interpretable GBM model shows potential for pre-treatment risk stratification in patients with HER2-positive breast cancer; however, its current predictive performance does not support stand-alone clinical decision-making.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-19
DOI
https://doi.org/10.1038/s41598-026-79913-0
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Interpretable machine learning for predicting residual cancer burden following neoadjuvant therapy in HER2 positive breast cancer: A real-world study

刘守贵, 林舜国, 郑彩红, 韩忠华 et al.
Scientific Reports
Breast Cancer Treatment Studies
article

Interpretable machine learning for predicting residual cancer burden following neoadjuvant therapy in HER2 positive breast cancer: A real-world study

刘守贵, 林舜国, 郑彩红, 韩忠华, Chengbin Fu, Yu Chen, Jinhua Huang, Yubin Chen, Liantao Guo, Junchao Lin, Honglin Zhang, Zhinan Chen, Chenyan Li, Chunsen Xu, Hui Han, Jingwen Zhuang
article en

Abstract

Accurate early prediction of response to neoadjuvant therapy (NAT) in HER2-positive breast cancer could support pre-treatment risk stratification. We conducted a retrospective real-world study of 692 patients treated between November 2018 and May 2025 at a tertiary center to develop interpretable machine-learning models for pre-treatment prediction of residual cancer burden (RCB; favorable: RCB 0–I vs. poor: RCB II–III). Least absolute shrinkage and selection operator identified nine routinely available predictors, and ten algorithms were trained with 10-fold cross-validation and grid search. Among them, a gradient boosting machine (GBM) achieved the best discrimination in the independent test set (AUC 0.796) with superior calibration and net clinical benefit. SHAP highlighted HER2 status, hormone-receptor status and clinical nodal stage as the strongest contributors, consistent with biological expectations. We implemented a Shiny web application for research and educational use. In a propensity score–matched comparison of trastuzumab–pertuzumab versus trastuzumab– pyrotinib regimens, no significant difference in achieving favorable RCB was observed. This interpretable GBM model shows potential for pre-treatment risk stratification in patients with HER2-positive breast cancer; however, its current predictive performance does not support stand-alone clinical decision-making.

Scientific Reports
Fujian Medical University (CN), Union Hospital (CN)
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon